{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:27:56Z","timestamp":1788956876073,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd012656.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000}}],"reference-count":111,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012656.pub3","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T14:26:53Z","timestamp":1597933613000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Primaquine alternative dosing schedules for preventing malaria relapse in people with<i>Plasmodium vivax<\/i>"],"prefix":"10.1002","author":[{"given":"Rachael","family":"Milligan","sequence":"additional","affiliation":[{"name":"Cochrane Infectious Diseases Group; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Daher","sequence":"additional","affiliation":[{"name":"Vice-Presidency of Research and Biological Collections; Oswaldo Cruz Foundation (FIOCRUZ); Rio de Janeiro Brazil"},{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Cochrane Response; Cochrane; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bergman","sequence":"additional","affiliation":[{"name":"Cochrane Response; Cochrane; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M","family":"Graves","sequence":"additional","affiliation":[{"name":"College of Public Health, Medical and Veterinary Sciences; James Cook University; Cairns Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD012656.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1590\/S0037-86822001000400006","article-title":"Assessment of the response to reduced treatment schemes for vivax malaria","volume":"34","author":"Abdon","year":"2001","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0035-9203(94)90305-0","article-title":"High dose of primaquine in primaquine resistant vivax malaria","volume":"88","author":"Bunnag","year":"1994","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.actatropica.2009.07.024","article-title":"Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days","volume":"112","author":"Carmona-Fonseca","year":"2009","journal-title":"Acta Tropica"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijid.2016.02.070","article-title":"Management of relapsing Plasmodium vivax malaria","volume":"45","author":"Chu","year":"2016","journal-title":"International Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD012656.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/cid\/ciy735","article-title":"Chloroquine versus dihydroartemisinin-piperaquine with standard high-dose primaquine given either for 7 days or 14 days in Plasmodium vivax malaria","volume":"68","author":"Chu","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4269\/ajtmh.13-0053","article-title":"Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru","volume":"91","author":"Durand","year":"2014","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"8","key":"10.1002\/14651858.CD012656.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e2861","DOI":"10.1371\/journal.pone.0002861","article-title":"A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan","volume":"3","author":"Leslie","year":"2008","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"579864","DOI":"10.1155\/2015\/579864","article-title":"Sustained release formulation of primaquine for prevention of relapse of Plasmodium vivax malaria: a randomized, double-blind, comparative, multicentric study","volume":"2015","author":"Pareek","year":"2015","journal-title":"Malaria Research and Treatment"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"347018","DOI":"10.1155\/2014\/347018","article-title":"Antirelapse efficacy of various primaquine regimens for Plasmodium vivax","volume":"2014","author":"Rajgor","year":"2014","journal-title":"Malaria Research and Treatment"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12936-018-2472-5","article-title":"A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India","volume":"17","author":"Saravu","year":"2018","journal-title":"Malaria Journal"},{"issue":"4","key":"10.1002\/14651858.CD012656.pub3-BIB0011|cit11","first-page":"197","article-title":"Clinical trial of the treatment of vivax malaria with shortened primaquine scheme compared to the traditional scheme","volume":"15","author":"Solari Soto","year":"2002","journal-title":"Revista de la Sociedad Peruana de Medicina Interna"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s12879-015-1276-2","article-title":"Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens","volume":"15","author":"IMPROV Study Group","year":"2015","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0013|cit13","unstructured":"IMPROV (Improving the radical cure of vivax malaria) clinicaltrials.gov\/ct2\/show\/NCT01814683"},{"issue":"10202","key":"10.1002\/14651858.CD012656.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","article-title":"Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial","volume":"394","author":"Taylor","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD012656.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/CDLI.8.5.891-894.2001","article-title":"Plasmodium vivax polymorphism in a clinical drug trial","volume":"8","author":"Adak","year":"2001","journal-title":"Clinical & Diagnostic Laboratory Immunology"},{"issue":"4","key":"10.1002\/14651858.CD012656.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4269\/ajtmh.2006.75.605","article-title":"Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia","volume":"75","author":"Alvarez","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0017|cit17","first-page":"51","article-title":"Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia","volume":"21","author":"\u00c1lvarez S\u00e1nchez","year":"2007","journal-title":"CES Medicine"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1128\/AAC.05566-11","article-title":"Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age","volume":"4","author":"Betuela","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e1002224","DOI":"10.1371\/journal.pmed.1002224","article-title":"Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens","volume":"14","author":"Chu","year":"2017","journal-title":"PLOS Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012656.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/cid\/ciy319","article-title":"Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria","volume":"67","author":"Chu","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4269\/ajtmh.1977.26.562","article-title":"Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine","volume":"26","author":"Clyde","year":"1977","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4269\/ajtmh.1974.23.310","article-title":"Combined chloroquine-primaquine therapy against vivax malaria","volume":"23","author":"Contacos","year":"1974","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12936-018-2192-x","article-title":"Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial","volume":"17","author":"Daher","year":"2018","journal-title":"Malaria Journal"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0024|cit24","first-page":"139","article-title":"Response of human Plasmodium to antimalarials on the Island of Saint Louis, State of Maranh\u00e3o, Brazil","volume":"26","author":"da Silva","year":"1984","journal-title":"Revista do Instituto de Medicina Tropical de Sa\u0303o Paulo"},{"issue":"8","key":"10.1002\/14651858.CD012656.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/00034983.1999.11813486","article-title":"Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections","volume":"93","author":"Gogtay","year":"1999","journal-title":"Annals of Tropical Medicine & Parasitology"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.76.203","article-title":"Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy","volume":"76","author":"Goller","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12936-018-2266-9","article-title":"Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan","volume":"17","author":"Hamid","year":"2018","journal-title":"Malaria Journal"},{"issue":"7","key":"10.1002\/14651858.CD012656.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e39645","DOI":"10.1371\/journal.pone.0039645","article-title":"Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata","volume":"7","author":"Kim","year":"2012","journal-title":"PLOS One"},{"issue":"10","key":"10.1002\/14651858.CD012656.pub3-BIB0029|cit29","first-page":"1086","article-title":"A study of relapsed cases of vivax malaria after the standard primaquine therapy","volume":"70","author":"Kimura","year":"1996","journal-title":"Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD012656.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4269\/ajtmh.2008.78.736","article-title":"High-dose primaquine regimens against relapse of Plasmodium vivax malaria","volume":"78","author":"Krudsood","year":"2008","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD012656.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"pii: e01965","DOI":"10.1128\/AAC.01965-18","article-title":"Monitoring the efficacy of chloroquine-primaquine therapy for uncomplicated Plasmodium vivax malaria in the main transmission hot spot of Brazil","volume":"63","author":"Ladeia-Andrade","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0035-9203(03)00041-5","article-title":"Compliance with 14-day primaquine therapy for radical cure of vivax malaria - a randomized placebo-controlled trial comparing unsupervised with supervised treatment","volume":"98","author":"Leslie","year":"2004","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0033|cit33","first-page":"120","article-title":"Abstract 337: A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium vivax in Pakistan","volume":"Suppl 6","author":"Leslie","year":"2008","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0034|cit34","first-page":"9","article-title":"Directly observed therapy with primaquine to reduce the recurrence rate of Plasmodium vivax infection along the Thai-Myanmar border","volume":"42","author":"Maneeboonyang","year":"2011","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4269\/ajtmh.1974.23.309","article-title":"Sensitivity of four Central American strains of Plasmodium vivax to primaquine","volume":"23","author":"Miller","year":"1974","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4 Supplement","key":"10.1002\/14651858.CD012656.pub3-BIB0036|cit36","first-page":"25","article-title":"Safety, tolerability, efficacy and pharmacokinetics of high dose, short course primaquine regimens in Papua New Guinean children","volume":"99","author":"Moore","year":"2018","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"11","key":"10.1002\/14651858.CD012656.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/infdis\/jit407","article-title":"A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia","volume":"208","author":"Pasaribu","year":"2013","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012656.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.44.6.1680-1685.2000","article-title":"Therapeutic responses to different antimalarial drugs in vivax malaria","volume":"44","author":"Pukrittayakamee","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0039|cit39","first-page":"443","article-title":"Initial response to single-dose of chloroquine, sulfadoxine-pyrimethamine and primaquine in children with vivax malaria","volume":"3","author":"Sabchareon","year":"1981","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0040|cit40","first-page":"62","article-title":"Comparison of treatment schedules for Plasmodium vivax infections in the Solomon Islands","volume":"20","author":"Saint-Yves","year":"1977","journal-title":"Papua and New Guinea Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/1475-2875-9-308","article-title":"Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border","volume":"9","author":"Takeuchi","year":"2010","journal-title":"Malaria Journal"},{"issue":"8","key":"10.1002\/14651858.CD012656.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/00034983.2000.11813599","article-title":"In-vivo sensitivity of Plasmodium vivax isolates from Rondonia (western Amazon region, Brazil) to regimens including chloroquine and primaquine","volume":"94","author":"Villalobos-Salcedo","year":"2000","journal-title":"Annals of Tropical Medicine & Parasitology"},{"issue":"8","key":"10.1002\/14651858.CD012656.pub3-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s10792-018-1003-2","article-title":"Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine\/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure","volume":"39","author":"Warrasak","year":"2019","journal-title":"International Ophthalmology"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0044|cit44","unstructured":"Safety and efficacy of primaquine for P. vivax clinicaltrials.gov\/ct2\/show\/NCT01837992"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12936-015-0678-3","article-title":"Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia","volume":"14","author":"Ar\u00e9valo-Herrera","year":"2015","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","article-title":"Primaquine: the risks and the benefits","volume":"13","author":"Ashley","year":"2014","journal-title":"Malaria Journal"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1471-4922(03)00005-9","article-title":"Can primaquine therapy for vivax malaria be improved?","volume":"19","author":"Baird","year":"2003","journal-title":"Trends in Parasitology"},{"issue":"9","key":"10.1002\/14651858.CD012656.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"Baird","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"36-57","DOI":"10.1128\/CMR.00074-12","article-title":"Evidence and implications of mortality associated with acute Plasmodium vivax malaria","volume":"26","author":"Baird","year":"2013","journal-title":"Clinical Microbiology Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1179\/2047773215Y.0000000016","article-title":"Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria","volume":"109","author":"Baird","year":"2015","journal-title":"Pathogens and Global Health"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12916-015-0531-0","article-title":"Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency","volume":"13","author":"Baird","year":"2015","journal-title":"BMC Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012656.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"e181449","DOI":"10.1001\/jamanetworkopen.2018.1449","article-title":"Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria","volume":"1","author":"Baird","year":"2018","journal-title":"JAMA Network Open"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD012656.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.16-0180","article-title":"Key knowledge gaps for Plasmodium vivax control and elimination","volume":"95","author":"Bassat","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-13-144","article-title":"Geographical variation in Plasmodium vivax relapse","volume":"13","author":"Battle","year":"2014","journal-title":"Malaria Journal"},{"issue":"14","key":"10.1002\/14651858.CD012656.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1301936","article-title":"Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria","volume":"369","author":"Bennett","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012656.pub3-BIB0056|cit56","first-page":"861","article-title":"The clinicopathologic manifestations of Plasmodium vivax malaria in children: a growing menace","volume":"7","author":"Bhattacharjee","year":"2013","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"10","key":"10.1002\/14651858.CD012656.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3201\/eid1910.130308","article-title":"Plasmodium vivax malaria during pregnancy, Bolivia","volume":"19","author":"Brutus","year":"2013","journal-title":"Emerging Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0058|cit58","first-page":"174","article-title":"Primaquine and relapses of Plasmodium vivax. Meta analysis of controlled clinical trials","volume":"18","author":"Carmona-Fonseca","year":"2015","journal-title":"Revista Brasileira de Epidemiologia"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"e3413","DOI":"10.1371\/journal.pntd.0003413","article-title":"Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors","volume":"9","author":"Cheng","year":"2015","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"10","key":"10.1002\/14651858.CD012656.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(15)00237-6","article-title":"Plasmodium vivax: a roadblock on the quest to eliminate malaria","volume":"15","author":"Cibulskis","year":"2015","journal-title":"Lancet Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012656.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4269\/ajtmh.1953.2.985","article-title":"Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency","volume":"2","author":"Coatney","year":"1953","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12916-019-1386-6","article-title":"The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis","volume":"17","author":"Simpson","year":"2019","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12916-014-0217-z","article-title":"Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia","volume":"12","author":"Douglas","year":"2014","journal-title":"BMC Medicine"},{"issue":"2624","key":"10.1002\/14651858.CD012656.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.101.2624.377","article-title":"Plasmodium vivax Chesson strain","volume":"101","author":"Ehrman","year":"1945","journal-title":"Science"},{"issue":"10","key":"10.1002\/14651858.CD012656.pub3-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004389.pub3","article-title":"Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine","author":"Galappaththy","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012656.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"e1814","DOI":"10.1371\/journal.pntd.0001814","article-title":"A long neglected world malaria map: Plasmodium vivax endemicity in 2010","volume":"6","author":"Gething","year":"2012","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/cid\/ciy235","article-title":"Primaquine pharmacokinetics in lactating women and breastfed infant exposures","volume":"86","author":"Gilder","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD012656.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008492.pub3","article-title":"Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria","author":"Gogtay","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0069|cit69","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008152.pub5","article-title":"Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission","author":"Graves","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012656.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4269\/ajtmh.2010.09-0521","article-title":"Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon","volume":"82","author":"Grietens","year":"2010","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0072|cit72","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"11","key":"10.1002\/14651858.CD012656.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map","volume":"9","author":"Howes","year":"2012","journal-title":"PLOS Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012656.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","article-title":"Global epidemiology of Plasmodium vivax","volume":"95","author":"Howes","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"7","key":"10.1002\/14651858.CD012656.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/512241","article-title":"Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites","volume":"195","author":"Imwong","year":"2007","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1475-2875-11-280","article-title":"Primaquine radical cure of Plasmodium vivax: a critical review of the literature","volume":"11","author":"John","year":"2012","journal-title":"Malaria Journal"},{"issue":"6","key":"10.1002\/14651858.CD012656.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4269\/ajtmh.1953.2.977","article-title":"Korean vivax malaria. IV. Curative effect of 15 milligrams of primaquine daily for 7 days","volume":"2","author":"Jackson","year":"1953","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/0972-9062.141760","article-title":"A prospective study on adult patients of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed infection from Bikaner, northwest India","volume":"51","author":"Kochar","year":"2014","journal-title":"Journal of Vector Borne Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012656.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"e0003872","DOI":"10.1371\/journal.pntd.0003872","article-title":"Plasmodium vivax diversity and population structure across four continents","volume":"9","author":"Koepfli","year":"2015","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD012656.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.2007.77.69","article-title":"Burden of malaria in India: retrospective and prospective view","volume":"77","author":"Kumar","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"8","key":"10.1002\/14651858.CD012656.pub3-BIB0081|cit81","first-page":"939-43","article-title":"Primaquine-tolerant vivax malaria in Thailand","volume":"91","author":"Looareesuwan","year":"1997","journal-title":"Annals of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0082|cit82","first-page":"455","article-title":"Malaria in the Eastern Outer Islands, British Solomon Islands protectorate","volume":"13","author":"Maffi","year":"1971","journal-title":"Parassitologia"},{"issue":"5","key":"10.1002\/14651858.CD012656.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1473-3099(11)70339-5","article-title":"Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study","volume":"12","author":"McGready","year":"2012","journal-title":"Lancet Infectious Diseases"},{"issue":"1-2 Suppl","key":"10.1002\/14651858.CD012656.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of Plasmodium vivax malaria","volume":"64","author":"Mendis","year":"2001","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD012656.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","article-title":"Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice","volume":"17","author":"Mikolajczak","year":"2015","journal-title":"Cell Host & Microbe"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0086|cit86","unstructured":"US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria www.mmv.org\/newsroom\/press-releases\/us-fda-approves-krintafel-tafenoquine-radical-cure-p-vivax-malaria"},{"issue":"9","key":"10.1002\/14651858.CD012656.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1473-3099(09)70177-X","article-title":"Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite","volume":"9","author":"Mueller","year":"2009","journal-title":"Lancet Infectious Diseases"},{"issue":"10029","key":"10.1002\/14651858.CD012656.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(16)00230-0","article-title":"The path to eradication: a progress report on the malaria-eliminating countries","volume":"387","author":"Newby","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cells, Molecules, and Diseases"},{"issue":"4","key":"10.1002\/14651858.CD012656.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010458.pub2","article-title":"Tafenoquine for preventing relapse in people with Plasmodium vivax malaria","author":"Rajapakse","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0091|cit91","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD012656.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"75-88","DOI":"10.1016\/S1473-3099(11)70315-2","article-title":"Malaria in pregnancy in the Asia-Pacific region","volume":"12","author":"Rijken","year":"2012","journal-title":"Lancet Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/1596-3519.117624","article-title":"Complications associated with Plasmodium vivax malaria: a retrospective study from a tertiary care hospital based in western Uttar Pradesh, India","volume":"12","author":"Rizvi","year":"2013","journal-title":"Annals of African Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012656.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"e1001891","DOI":"10.1371\/journal.pmed.1001891","article-title":"Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model","volume":"12","author":"Robinson","year":"2015","journal-title":"PLOS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012656.pub3-BIB0095|cit95","first-page":"62-5","article-title":"Comparison of treatment schedules for Plasmodium vivax infections in the Solomon Islands","volume":"20","author":"Saint-Yves","year":"1977","journal-title":"Papua and New Guinea Medical Journal"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD012656.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4269\/ajtmh.1977.26.1116","article-title":"Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose","volume":"26","author":"Schmidt","year":"1977","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"341862","DOI":"10.1155\/2013\/341862","article-title":"Clinical manifestations, treatment, and outcome of hospitalized patients with Plasmodium vivax malaria in two Indian States: a retrospective study","volume":"2013","author":"Singh","year":"2013","journal-title":"Malaria Research and Treatment"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/AAC.01879-12","article-title":"Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia","volume":"57","author":"Sutanto","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12936-018-2378-2","article-title":"Primaquine 30 mg\/day versus 15 mg\/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison","volume":"17","author":"Valdes","year":"2018","journal-title":"Malaria Journal"},{"issue":"3","key":"10.1002\/14651858.CD012656.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0101|cit101","first-page":"267","article-title":"The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria","volume":"25","author":"Vivona","year":"1961","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in Plasmodium vivax malaria","volume":"10","author":"White","year":"2011","journal-title":"Malaria Journal"},{"issue":"1827","key":"10.1002\/14651858.CD012656.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"20160048","DOI":"10.1098\/rspb.2016.0048","article-title":"Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria","volume":"283","author":"White","year":"2016","journal-title":"Proceedings of the Royal Society B"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0104|cit104","unstructured":"World Health Organization Methods for surveillance of antimalarial drug efficacy www.who.int\/iris\/handle\/10665\/44048"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0105|cit105","volume-title":"Guidelines for the Treatment of Malaria","author":"World Health Organization","year":"2015"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0106|cit106","unstructured":"World Health Organization Eliminating malaria apps.who.int\/iris\/bitstream\/10665\/205565\/1\/WHO_HTM_GMP_2016.3_eng.pdf"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0107|cit107","unstructured":"World Health Organization World malaria report 2017 apps.who.int\/iris\/bitstream\/handle\/10665\/259492\/9789241565523-eng.pdf"},{"key":"10.1002\/14651858.CD012656.pub3-BIB0108|cit108","unstructured":"World Health Organization World malaria report 2019 www.who.int\/publications-detail\/world-malaria-report-2019"},{"issue":"4","key":"10.1002\/14651858.CD012656.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"183","DOI":"10.25100\/cm.v46i4.2098","article-title":"Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: a systematic review and meta-analysis","volume":"46","author":"Zuluaga-Idarraga","year":"2015","journal-title":"Colombia M\u00e9dica"},{"issue":"5","key":"10.1002\/14651858.CD012656.pub3-BIB0110|cit110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012656","article-title":"Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria","author":"Milligan","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012656.pub3-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012656.pub2","article-title":"Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria","author":"Milligan","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T06:55:43Z","timestamp":1723445743000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012656.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":111,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012656.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]}}}